MILAN--(BUSINESS WIRE)--Sorin Group (MIL:SRN) (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the purchase of cardiac surgery cannulae manufacturing activities from its supplier Bioengineering Laboratories S.p.A. (“BEL”) located in Cantù (Como), Italy.
Help employers find you! Check out all the jobs and post your resume.
